|

Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors

RECRUITINGSponsored by Sun Yat-sen University
Actively Recruiting
SponsorSun Yat-sen University
Started2022-11-01
Est. completion2024-10-01
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06206681

Summary

This study aims to assess the long-term efficacy and safety of ultrapulse carbon dioxide (CO₂) laser excision in the treatment of eyelid tumors, including xanthelasma, pigmented nevi, keratoses, and so on.

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Clinically diagnosed with eyelid lesions, including xanthelasma, pigmented nevi, keratoses, and so on.
* No history of photosensitivity, bleeding, or coagulation disorders
* Willing to attend follow-up appointments as scheduled

Exclusion Criteria:

* Presence of infection in the target area
* Allergy to lidocaine
* Keloid-prone or poor skin repair ability
* Pregnant or lactating
* Recent history of severe infectious diseases, active skin diseases, or major diseases affecting the cardiovascular, liver, kidney, endocrine, and hematopoietic systems
* History of malignant tumors or immune system disorders

Conditions5

CancerEyelid TumorKeratosisPigmented NeviXanthelasma Palpebrarum

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.